EcoDrugPlus

Ribosomal Protein L36

Ensembl ID : ENSPSNG00000017170
Gene Symbol: RPL36
3 Cross references
211 Possible Orthologues:

Ribosomal Protein L36a

Ensembl ID : ENSPSNG00000019995
Gene Symbol: RPL36A
3 Cross references
81 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSPSNG00000003299
Gene Symbol: RPL37
3 Cross references
100 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSPSNG00000015410
Gene Symbol: RPL37A
3 Cross references
145 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSPSNG00000021704
Gene Symbol: RPL38
3 Cross references
202 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSPSNG00000008240
Gene Symbol: RPL6
2 Cross references
371 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSPSNG00000005013
Gene Symbol: RPL7
2 Cross references
170 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSPSNG00000005425
Gene Symbol: RPL8
2 Cross references
211 Possible Orthologues:

Ribosomal Protein S11

Ensembl ID : ENSPSNG00000013005
Gene Symbol: RPS11
3 Cross references
238 Possible Orthologues:

Ribosomal Protein S14

Ensembl ID : ENSPSNG00000016534
Gene Symbol: RPS14
2 Cross references
130 Possible Orthologues:

Ribosomal Protein S15

Ensembl ID : ENSPSNG00000013713
Gene Symbol: RPS15
2 Cross references
174 Possible Orthologues:

Ribosomal Protein S16

Ensembl ID : ENSPSNG00000021148
Gene Symbol: RPS16
3 Cross references
263 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).